SCHEMBL21359504

SCHEMBL21359504

O=C(O)c1cc(-c2cn[nH]c2)ccc1-c1ccc2ccccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACMSD Q8TDX5 1/20 0.54
▸ CLK2 P49760 1/20 0.51
▸ HIPK1 Q86Z02 1/20 0.51
▸ DYRK2 Q92630 1/20 0.51
▸ HIPK2 Q9H2X6 1/20 0.51
▸ HIPK3 Q9H422 1/20 0.51
▸ CLK4 Q9HAZ1 1/20 0.51
▸ MIF P14174 1/20 0.50
▸ SLC6A2 P23975 1/20 0.47
▸ SLC6A4 P31645 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47
▸ ROCK2 O75116 6/20 0.46
▸ CA12 O43570 1/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ SOS1 Q07889 1/20 0.45
▸ HIF1A Q16665 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22861261 0.88 AKT1 (0.56) ACMSDCLK2HIPK1HIPK2HIPK3
SCHEMBL22861323 0.86 SLC6A3 (0.64) CLK2HIPK1DYRK2HIPK2HIPK3
SCHEMBL22861262 0.84 MCL1 (0.52) ACMSDROCK2AKT1AKT2MEN1
SCHEMBL2458568 0.83 AKT2 (0.59) CLK2HIPK1DYRK2HIPK2HIPK3
SCHEMBL21359523 0.83 MIF (0.66) ACMSDCLK2HIPK1DYRK2HIPK2
SCHEMBL21359495 0.79 ROCK2 (0.43) ACMSDCLK2HIPK1DYRK2HIPK2
SCHEMBL21359390 0.77 MIF (0.51) MIFROCK2AKT1AKT2ROCK1
SCHEMBL29236146 0.76 ACMSD (0.55) ACMSDSLC6A2SLC6A4SLC6A3CA12
SCHEMBL2397762 0.75 AKT1 (0.58) ROCK2AKT1AKT2ROCK1RAB9A
SCHEMBL29550614 0.75 AKT1 (0.58) ROCK2AKT1AKT2ROCK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230057076-A1 Pyrazole-Containing Macrophage Migration Inhibitory Factor Inhibitors UNIV YALE (US) 2023-02-23 — — US disclosed
US-20210002264-A1 Pyrazole-Containing Macrophage Migration Inhibitory Factor Inhibitors UNIV YALE (US) 2021-01-07 — — US disclosed
WO-2019178480-A1 PYRAZOLE-CONTAINING MACROPHAGE MIGRATION INHIBITORY FACTOR INHIBITORS YALE UNIVERSITY (US) 2019-09-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210002264-A1 Pyrazole-Containing Macrophage Migration Inhibitory Factor Inhibitors MIF, MMP12, CSF1R ACMSD 4775/4885CLK2 2438/4885HIPK1 1342/4885
US-20230057076-A1 Pyrazole-Containing Macrophage Migration Inhibitory Factor Inhibitors MIF, MMP12, CSF1R ACMSD 4774/4885CLK2 2327/4885HIPK1 1104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback